2196.HK 600196.SHG
111 Inc. is a healthcare company

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (2196.HK; 600196.SH) said on Monday that Shanghai Fosun High Technology, a subsidiary of Fosun International (0656.HK), has pledged 198 million shares of the Shanghai-listed A-shares it holds in Fosun Pharma to banking giant ICBC. The pledged shares account for 7.4% of Fosun Pharma’s total, and Fosun High Tech will use proceeds raised through the share pledge to repay debts.

Together with previously pledged shares, Fosun has pledged a total of nearly 720 million of Fosun Pharma’s A-shares, accounting for 26.65% of its total.

Fosun Pharma said agreements involving 433 million of its pledged shares will expire within one year, accounting for approximately 16.2% of the company’s total shares, involving an amount of 4.36 billion yuan.

By Lau Chi Hang

To subscribe to Bamboo Works weekly free newsletter, click  here

Recent Articles

Video podcast: Cango to build on bitcoin mining foundation with HPC pivot

Cango details the strategic pivot to transform from a pure-play crypto miner into an integrated energy and high-performance computing (HPC) platform. The multi-phase strategy leverages Cango's existing energy and computing infrastructure as a foundation to build a more diverse business model with revenues from mining, AI client services, and energy trading.